Nanomaterials for Cancer Diagnosis and Therapy II
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Nanochemistry".
Deadline for manuscript submissions: closed (30 September 2022) | Viewed by 3028
Special Issue Editors
Interests: nanotechnology; 2D nanoparticles; theranostics; cancer therapy; biocompatibility; detection
Special Issues, Collections and Topics in MDPI journals
Interests: theranostics; cancer therapy; biocompatibility; drug delivery; toxicology; screening; targeting moieties
Interests: nanotechnology; 2D nanoparticles; cancer therapy; biocompatibility; drug delivery; toxicology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanotechnology has become a powerful weapon in the fight against cancer. With the development of precisely engineered nanoparticles able to overcome biological barriers, they specifically recognize and destroy a single type of cancer cell, and accumulate preferentially in tumors, offering a new and potent arsenal to oncologists. Inorganic and organic (or polymeric) nanoparticles have been widely explored for therapeutic and diagnostic applications in cancer treatment. Normally, single nanoparticles are often used and functionalized with organic or polymeric ligands to improve their stability, biocompatibility, and functionality. While individual nanoparticles are no doubt exciting, an ensemble of interacting nanoparticles can exhibit a rich variety of novel and extremely useful collective properties that can be radically different from their individual characteristics. These new synergistic properties originate from coupling interactions in the ensemble of nanoparticles. It is, therefore, expected that the ability to design hybrid structures with tailored spatial arrangements of nanoparticles may facilitate the utilization of nanoparticles in biomedical applications. Recent advances in nanomedicine have raised exciting possibilities for future nanoparticle applications in personalized cancer therapy, and new strategies for building hybrid nanostructures are offering interesting platforms, such as effective multimodality cancer imaging (i.e., photothermal, photoacoustic, and magnetic resonance imaging) and combinational cancer therapy (i.e., the photothermal ablation of tumors, photodynamic therapy, and targeted delivery-based chemotherapy).
In this Special Issue, we invite investigators to contribute original research and review articles related to the application of hybrid nanoparticles as multifunctional platforms in the treatment and early diagnosis of cancer, with particular interest in research directed toward improving the effectivity and selectivity properties of different nanoparticles for treatment or bioimaging purposes. Potential topics include, but are not limited to:
- Theranostic nanoparticles for cancer treatment;
- Nanoparticles as contrast agents for bioimaging;
- Nanoparticles as biosensors;
- Novel therapies based on nanomaterials for cancer treatment and diagnosis;
- Clinical studies and therapeutic and diagnostic efficacy of anticancer nanoparticles;
- Biocompatibility and toxicity studies of nanoparticles for cancer treatment.
Prof. Dr. Tapas K. Mandal
Prof. Dr. Partha Roy
Dr. Nargish Parvin
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanotechnology
- hybrid nanoparticles
- theranostics
- cancer therapy
- biocompatibility
- imaging
- drug delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
